|SEQ_NO||1||Date of announcement||2020/02/10||Time of announcement||18:18:26|
|Subject||Announcement of TTY Biopharm's unaudited income information in Jan 2020|
|Date of events||2020/02/10||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2020/02/10
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $370,093 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $106,362 thousands, and a consolidated income before tax of $123,974 thousands in Jan 2020; net income attributed to stockholders of the company was $96,238 thousands; EPS is $0.39.
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.